Pomerantz Appointed Co-Lead Counsel in AstraZeneca Securities Litigation

On April 28, 2021, U.S. District Judge J. Paul Oetken of the Southern District of New York appointed Pomerantz LLP as Co-Lead Counsel on behalf of Co-Lead Plaintiff Nuggehalli Balmukund Nandkumar in In re AstraZeneca plc Sec. Litig., 21-cv-722 (S.D.N.Y.), a securities action brought on behalf of a class of defrauded investors concerning allegations that AstraZeneca plc failed to disclose to investors that its clinical trials…